Skip to main content

hemgenix

Generic: etranacogene dezaparvovec·Brand: Hemgenix

hemgenix: 1 clinical trial tracked.

hemgenix evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about hemgenix, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (1)

An Observational Post-authorization Long-term Follow-up Study to Characterize the Effectiveness and Safety of HEMGENIX® (Etranacogene Dezaparvovec) in Patients With Hemophilia B

NCT06008938Registry updated 2026-02-19·N/A
Recruiting

Primary endpoint: Bleeding Rate (all bleeds) - HEMGENIX Cohort

Observational500 targetStarted 2023-06Completion 2043-0812 sites · Austria, Denmark, France, Germany…CSL Behring